Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-1beta | 3 | 2013 | 70 | 0.470 |
Why?
|
| Hepatitis B, Chronic | 1 | 2013 | 10 | 0.460 |
Why?
|
| Dipeptidases | 1 | 2013 | 9 | 0.460 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 172 | 0.390 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 220 | 0.380 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 234 | 0.370 |
Why?
|
| Trans-Activators | 3 | 2013 | 174 | 0.370 |
Why?
|
| Liver | 1 | 2013 | 479 | 0.370 |
Why?
|
| MicroRNAs | 2 | 2013 | 426 | 0.360 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 239 | 0.300 |
Why?
|
| Interferon Regulatory Factors | 1 | 2007 | 17 | 0.290 |
Why?
|
| STAT1 Transcription Factor | 1 | 2007 | 35 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 356 | 0.170 |
Why?
|
| Cell Line | 4 | 2012 | 1354 | 0.160 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 19 | 0.120 |
Why?
|
| Genes, Immediate-Early | 1 | 2013 | 8 | 0.120 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 30 | 0.120 |
Why?
|
| Liver Cirrhosis | 1 | 2013 | 52 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 2231 | 0.110 |
Why?
|
| Aryldialkylphosphatase | 1 | 2012 | 10 | 0.110 |
Why?
|
| Osteomyelitis | 1 | 2012 | 17 | 0.110 |
Why?
|
| Collagen | 1 | 2013 | 172 | 0.110 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 46 | 0.110 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2012 | 52 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 111 | 0.100 |
Why?
|
| Mice | 3 | 2013 | 5913 | 0.100 |
Why?
|
| Disease Progression | 1 | 2013 | 601 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2009 | 16 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 628 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 578 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 78 | 0.080 |
Why?
|
| Humans | 9 | 2013 | 37093 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 128 | 0.080 |
Why?
|
| Cytomegalovirus | 1 | 2008 | 40 | 0.080 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 46 | 0.080 |
Why?
|
| Response Elements | 1 | 2007 | 56 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2013 | 681 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 118 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 61 | 0.070 |
Why?
|
| Animals | 4 | 2013 | 15081 | 0.070 |
Why?
|
| Young Adult | 2 | 2013 | 4268 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2007 | 928 | 0.060 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2003 | 8 | 0.060 |
Why?
|
| Adult | 3 | 2013 | 11712 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 9 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 408 | 0.040 |
Why?
|
| Male | 3 | 2013 | 20025 | 0.040 |
Why?
|
| Female | 3 | 2013 | 20969 | 0.040 |
Why?
|
| Prognosis | 2 | 2013 | 739 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2013 | 1207 | 0.040 |
Why?
|
| Transfection | 2 | 2008 | 523 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 14 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 29 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2013 | 29 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 64 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2013 | 90 | 0.030 |
Why?
|
| Biological Transport | 1 | 2013 | 185 | 0.030 |
Why?
|
| Glucose | 1 | 2013 | 230 | 0.030 |
Why?
|
| Monocytes | 1 | 2013 | 257 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2009 | 34 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 34 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 22 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 108 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2009 | 66 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 6741 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1130 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2009 | 106 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 275 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 98 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 1095 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 448 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 623 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 807 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 409 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 859 | 0.020 |
Why?
|
| Hela Cells | 1 | 2008 | 366 | 0.020 |
Why?
|
| Middle Aged | 2 | 2012 | 10129 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 938 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2009 | 1518 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 515 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 320 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2003 | 7 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 2379 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2003 | 25 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2003 | 16 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2003 | 61 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 100 | 0.010 |
Why?
|
| Mammals | 1 | 2003 | 105 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 325 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 389 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 515 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 5363 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 190 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 3562 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 808 | 0.010 |
Why?
|